Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Rating of “Hold” by Analysts

Roche Holding AG (OTCMKTS:RHHBY) has received a consensus rating of “Hold” from the six research firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating on the company.

RHHBY has been the topic of a number of recent research reports. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Morgan Stanley initiated coverage on shares of Roche in a research report on Wednesday, February 12th. They issued an “equal weight” rating on the stock.

Roche Stock Performance

Roche stock opened at $40.85 on Wednesday. Roche has a twelve month low of $29.20 and a twelve month high of $42.43. The business has a fifty day moving average of $37.14 and a two-hundred day moving average of $38.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

Institutional Investors Weigh In On Roche

A number of large investors have recently modified their holdings of RHHBY. HighPoint Advisor Group LLC raised its position in shares of Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after purchasing an additional 304 shares during the last quarter. Hantz Financial Services Inc. lifted its stake in shares of Roche by 0.9% during the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after buying an additional 305 shares during the period. Canopy Partners LLC grew its holdings in shares of Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares during the last quarter. Brooklyn Investment Group increased its position in shares of Roche by 36.6% in the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock valued at $48,000 after acquiring an additional 363 shares during the period. Finally, Altrius Capital Management Inc raised its stake in Roche by 0.3% in the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after acquiring an additional 603 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.